Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRT27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,202
Award facts
- Contract value 100% obligated
- $4,202.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,202.00 to AmerisourceBergen Drug Corp for HEPLISAV-B, a hepatitis B vaccine supplied in 20 mcg/0.5 mL syringes. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen's IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This specific delivery order for HEPLISAV-B vaccine reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling routine immunization requirements for military and defense personnel.
Quick answers
Who was awarded contract SPE2DB25FRT27?
SPE2DB25FRT27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FRT27 worth?
The government has obligated $4,202 on SPE2DB25FRT27.
Is contract SPE2DB25FRT27 an order under another contract?
Yes. SPE2DB25FRT27 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRT27 competed?
The extent of competition for SPE2DB25FRT27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award